MET and cancer: Similar cytoplasmic functions were found for CHROMR in certain cancers where it targets miR-27b-3p, miR-186-5p, and miR-1299, repressing cell cycle-regulator genes CNNM1, MET, and NCAPG2, leading to accelerated cancer growth and progression [28,29,32].